Lai Wang
Equibles does not estimate personal net worth.
About Lai Wang
Lai Wang has spoken on 2 earnings calls across 1 company, most recently for BeOne Medicines Ltd. on August 5, 2026. The companies whose calls Lai Wang spoke on are classified in the Healthcare sector.
Lai Wang on recent calls
“Across our portfolio, we'll continue to deliver meaningful progress. Starting with hematology, John already highlighted the positive readout from the Mangrove study in treatment-naive mental cell lymphoma.”
“2025 has been a standard-out year for B1R&D. Most notably, it was a breakout year for SONU. We achieved our first global approvals in China for relaxed refractory MCL and CLL.”
Affiliation history
-
BeOne Medicines Ltd. (ONC)
Proxy statement
Start not stated–2023-04-27
Last confirmed by a filing; no departure on record